drugset
Drugs / autologous neuroblastoma vaccine
last change Oct 2009 re-read 3 minutes ago

autologous neuroblastoma vaccine

Vaccine

Developed for
neuroblastoma
Investigated by
Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine · Malcolm Brenner

Trials 1

today NCT00048386 · Ph 1
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00048386 Nov 1999 → Dec 2004 neuroblastoma Malcolm Brenner Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as autologous neuroblastoma vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00048386 ↗
Modality Vaccine “Vaccine modified for secretion of IL-2 will be used.” NCT00048386 ↗
Route Subcutaneous “treatment with subcutaneous injections of autologous neuroblastoma cells” NCT00048386 ↗